Trial Profile
Phase II trial of CPT-11 [irinotecan], cisplatin and tamoxifen in patients with recurrent malignant glioma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2006
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Irinotecan (Primary) ; Tamoxifen (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 31 Jan 2006 New trial record.